HIPAA, SOC 2, and HL7/FHIR fluent. Built for payer, provider, and health-tech buying committees where the wrong message kills the deal.
A vertical research engine that tracks EHR migrations, payer-provider JVs, CMS rule windows, and clinical leadership changes, and assembles a deep account dossier before your first outreach.
Four buying universes, four distinct motions. We engineer outreach to the committee shape of each, not a generic enterprise template.
Titles: CMO, VP Network, Director of Care Management, Actuarial.
Risk-adjusted thinking, contracting cycles, network strategy.
Titles: CMIO, CNIO, VP Revenue Cycle, VP Population Health, CISO.
Clinical, operational, and security committees that move in parallel.
Titles: CRO, VP Sales, VP Partnerships, Head of Clinical Ops.
Selling into IDNs, payers, and risk-bearing entities, often simultaneously.
Titles: Commercial Ops, Field Medical, RWE leadership.
Evidence-led buyers with regulated commercial constraints.
Compliance literacy is not a slide. It shows up in restraint: no PHI in outreach, BAA-readiness when the engagement requires it, security questionnaires anticipated, and procurement timelines respected rather than fought.
A vertical-specialized signal stack. We watch the surface where healthcare buying decisions actually originate, then time outreach to the window of relevance.
ICP defined at the IDN, health-system, and payer tier. Account universe built around contract structure, footprint, and committee shape, not generic firmographics.
Committee org charts, vendor footprint, prior pilots, integration topology, and procurement history mapped before a single message is written.
Multi-threaded across clinical, IT and security, finance, and procurement. Each persona engaged on its own frame, with shared narrative threading across the committee.
Engagement designed to survive 9 to 18 month cycles, leadership rotation, and pilot-to-enterprise expansion windows. Senior continuity is the asset.
Nine-to-eighteen-month cycles. Seven-to-twelve-stakeholder committees. Procurement gauntlets that prefer to say no. Security reviews that can stall a deal for two quarters. Pilot-to-enterprise expansion that requires executive continuity, not handoffs.
Junior SDRs get filtered out at the gateway: gatekeepers, security questionnaires, clinical objections, procurement structure. Senior operators get into the room because they speak the language the committee uses internally, and because they can hold a multi-threaded narrative across a multi-quarter cycle without losing the thread.
That is the bet we make: vertical-specialized, executive-grade, complex-cycle, multi-threaded, insight-led, compounding.
Multi-threaded across CMIO, CISO, VP Revenue Cycle, and procurement. Built around CMS rule windows and EHR migration timing. The full story is available on a call, under NDA.
Hear the full story on a callOur copy framework is built so PHI never enters a sequence. Personalization is sourced from public signals (leadership changes, financial filings, RFPs, conference activity, EHR announcements) and from structured account research. Reps are trained to recognize and refuse any inbound that surfaces PHI.
Where the engagement requires it, yes. We work with your legal and security teams to align on a Business Associate Agreement that reflects the scope of the work. In most outbound engagements, BAA is not triggered because no PHI is processed, and we document that posture clearly.
Yes. We anticipate them, time them into the sequence, and pre-stage the artifacts your prospect's security team will ask for. The goal is to turn the security review from a deal-killer into a credibility moment.
Nine to eighteen months is the realistic band for enterprise health system and payer deals. Digital-health-to-digital-health motions can move faster. We design pipeline and forecasting around that reality rather than against it.
Payers buy through medical economics, network strategy, and risk-adjusted ROI. Providers buy through clinical operations, revenue cycle, and security committees. The committee shape, the language, the proof points, and the procurement choreography are different. We treat them as separate motions with separate playbooks.
On a qualified call, yes. We anonymize publicly and share specifics under NDA. Healthcare is a small world and we protect client relationships accordingly.
It shows up in restraint. We do not lead with acronyms. We use HL7 v2 and FHIR R4 fluency to ask the right qualifying questions, to frame integration risk honestly, and to earn the technical buyer's trust without claiming more than the product does.
Multi-quarter, designed in chapters. A typical engagement runs six to twelve months at a minimum because the buying committees, procurement gauntlets, and security reviews compound over that horizon. Shorter engagements rarely move late-stage healthcare deals.
A working session with a senior healthcare operator. We map your committee, your cycle, your signal stack, and the gap between where outreach is landing and where it should.
Book the diagnosticA senior-operator reference for payer, provider, and health-tech committees. We will send it to your inbox within 24 hours.